🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation or Conventional Rehabilitation Combined With Digital Therapy

RecruitingNAAges 18 Years - anyAllGCS Ramsay Santé pour l'Enseignement et la Recher…
NCT07030764 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Traumatic injury to the knee joint, such as rupture of the anterior cruciate ligament (ACL), can compromise the voluntary activation capacity of the quadriceps despite the anatomical integrity of the nerve and muscle structures responsible for contraction. This phenomenon is commonly known as 'arthrogenic muscle inhibition' (AMI). AMI is a major limiting factor in recovery and rehabilitation after ACL rupture, and a potential cause of functional disability if left undiagnosed and untreated. Traditional rehabilitation protocols for ACL reconstruction do not adequately address the underlying neuromuscular deficits caused by AMI, leading to sub-optimal recovery and prolonged rehabilitation. Furthermore, patient adherence to these protocols, outside of supervised settings, is variable and often poor, which can further delay recovery Recent advances in digital health technologies offer new

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient, male or female, aged ≥ 18 years * Patient with a scheduled primary ACL reconstruction * Patient with a smartphone and able to use a mobile application on a smartphone * Patient affiliated to or benefiting from a social security scheme * French-speaking patient who has signed an informed consent form Exclusion Criteria: * Patients with residual AMI * Patient with previous ipsi or contralateral knee surgery * Patient with a multi-ligament injury * Patient with contraindications to physical exercise: severe cardiovascular disease or uncontrolled metabolic disease * Patients with cognitive problems * Patient without internet access * Patient taking part in another study * Pregnant or breast-feeding women * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
💊

What it tests

  • DOCT'UP
  • Physiotherapy
📍

Where

1 site
Hôpital Privé Jean Mermoz
Lyon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy